Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for medical industry professionals · Saturday, November 17, 2018 · 468,651,376 Articles · 3+ Million Readers

Global Infertility Market Charged to grow at the CAGR of 4.52 % from 2015 to 2019


Wise.Guy. adds “Global Infertility Market 2015-2019” reports to its Database.

PUNE, INDIA, December 8, 2017 / --

About Infertility 
Infertility is a widespread problem, and it is the inability to conceive after having regular unprotected sex. In one-third of the cases, infertility is because of either female infertility factors or male infertility factors. In rest of the cases, the cause is either unknown or a combination of both male and female factors. In males, infertility is due to a couple of factors including low sperm production, abnormal sperm function, or blockages that prevent the delivery of sperm. The cause of infertility can be difficult to diagnose, but many treatments are available. Treatment options depend on underlying problems.

TechNavio's analysts forecast the Global Infertility market to grow at a CAGR of 4.52 percent over the period 2014-2019.

Covered in this Report 
This report covers the present scenario and the growth prospects of the Global Infertility market for the period 2015-2019. The Global Infertility market can be divided into two segments: Infertility Drugs and Infertility Devices. To calculate the market size, the report considers revenue generated from the sales of various drugs and devices used in the treatment of infertility.

TechNavio's report, the Global Infertility Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Infertility market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions 
• Americas 

Key Vendors 
• Bayer Healthcare 
• CooperSurgical 
• Ferring Pharmaceuticals 
• Merck & Co.

Other Prominent Vendors 
• Abbott Laboratories 
• AbbVie 
• Actavis 
• Apricus Biosciences 
• AstraZeneca 
• Bristol-Myers Squibb 
• Dong-A Socio 
• Elelixis Diagnostics 
• Eli Lily 
• Halotech DNA 
• HRA Pharma 
• Invo Bioscience 
• Medical Electronic Systems 
• Novartis 
• Pfizer 
• PregLem 
• Sanofi 
• Vivus


Request For Sample Report @                


Market Driver 
• Increase in Aging Population 
• For a full, detailed list, view our report

Market Challenge 
• Patent Expires of Major Blockbuster Drugs 
• For a full, detailed list, view our report

Market Trend 
• Increase in Awareness 
• For a full, detailed list, view our report

Key Questions Answered in this Report 
• What will the market size be in 2019 and what will the growth rate be? 
• What are the key market trends? 
• What is driving this market? 
• What are the challenges to market growth? 
• Who are the key vendors in this market space? 
• What are the market opportunities and threats faced by the key vendors? 
• What are the strengths and weaknesses of the key vendors?

 Table of Contents:

Executive Summary 
02. List of Abbreviations 
03. Scope of the Report 
03.1 Market Overview 
    03.2 Product Offerings 
04. Market Research Methodology 
04.1 Market Research Process 
    04.2 Research Methodology 
05. Introduction 
06. Disease Overview 
07. Country Overview 
      07.1.1 US 
      07.1.2 UK 
08. Market Landscape 
09. Market Segmentation by Type 
10. Market Segmentation by Underlying Cause 
11. Geographical Segmentation 
12. Buying Criteria 
13. Market Growth Drivers 
14. Drivers and their Impact 
15. Market Challenges 
16. Impact of Drivers and Challenges 
17. Market Trends 
18. Trends and their Impact 
19. Vendor Landscape 
    19.1 Competitive Scenario 
      19.1.1 Key News 
      19.1.2 Licensing and Collaborations 
      19.1.3 Mergers and Acquisitions 
    19.2 Market Share Analysis 2014 
    19.3 Other Prominent Vendors 
20. Key Vendor Analysis 
    20.1 Bayer HealthCare 
      20.1.1 Key Facts 
      20.1.2 Business Overview 
      20.1.3 Business Segmentation by Revenue 2013 
      20.1.4 Business Segmentation by Revenue 2012 and 2013 
      20.1.5 Geographical Segmentation by Revenue 2013 
      20.1.6 Business Strategy 
      20.1.7 Recent Developments 
      20.1.8 SWOT Analysis 
    20.2 CooperSurgical 
      20.2.1 Key Facts 
      20.2.2 Business Description 
      20.2.3 Business Segmentation 
      20.2.4 Business Segmentation by Revenue 
      20.2.5 Business Segmentation by Revenue 2012 and 2013 
      20.2.6 Business Strategy 
      20.2.7 Key Developments 
      20.2.8 SWOT Analysis 
    20.3 Ferring Pharmaceuticals 
      20.3.1 Key Facts 
      20.3.2 Business Overview 
      20.3.3 SWOT Analysis 
    20.4 Merck & Co. Inc. 
      20.4.1 Key Facts 
      20.4.2 Business Overview 
      20.4.3 Business Segmentation by Revenue 2013 
      20.4.4 Business Segmentation by Revenue 2012 and 2013 
      20.4.5 Sales by Geography 
      20.4.6 Business Strategy 
      20.4.7 Key Developments 
      20.4.8 SWOT Analysis 


Enquiry Before Buy @                                   




Partner Relations & Marketing Manager

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here

Powered by EIN Presswire